PMC:509410 / 2927-3598 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE-old TextAE

Id Subject Object Predicate Lexical cue
T728 0-6 NN denotes Muscle
T730 7-12 NN denotes fiber
T729 13-26 NN denotes specification
T731 27-34 VBZ denotes appears
T732 35-37 TO denotes to
T734 38-40 VB denotes be
T733 41-51 VBN denotes associated
T735 52-56 IN denotes with
T736 57-64 NN denotes obesity
T737 65-68 CC denotes and
T738 69-77 NN denotes diabetes
T739 77-78 . denotes .
T740 78-192 sentence denotes For instance, rodents that gain the most weight on high-fat diets possess fewer type I fibers (Abou et al. 1992).
T741 79-82 IN denotes For
T743 83-91 NN denotes instance
T744 91-93 , denotes ,
T745 93-100 NNS denotes rodents
T746 101-105 WDT denotes that
T747 106-110 VBP denotes gain
T748 111-114 DT denotes the
T750 115-119 JJS denotes most
T749 120-126 NN denotes weight
T751 127-129 IN denotes on
T752 130-134 JJ denotes high
T754 134-135 HYPH denotes -
T753 135-138 NN denotes fat
T755 139-144 NNS denotes diets
T742 145-152 VBP denotes possess
T756 153-158 JJR denotes fewer
T758 159-163 NN denotes type
T759 164-165 CD denotes I
T757 166-172 NNS denotes fibers
T760 173-174 -LRB- denotes (
T761 174-178 NNP denotes Abou
T762 179-181 FW denotes et
T763 182-185 FW denotes al.
T764 186-190 CD denotes 1992
T765 190-191 -RRB- denotes )
T766 191-192 . denotes .
T767 192-398 sentence denotes In obese patients, skeletal muscle has been observed to have reduced oxidative capacity, increased glycolytic capacity, and a decreased percentage of type I fibers (Hickey et al. 1995; Tanner et al. 2002).
T768 193-195 IN denotes In
T770 196-201 JJ denotes obese
T771 202-210 NNS denotes patients
T772 210-212 , denotes ,
T773 212-220 JJ denotes skeletal
T774 221-227 NN denotes muscle
T775 228-231 VBZ denotes has
T776 232-236 VBN denotes been
T769 237-245 VBN denotes observed
T777 246-248 TO denotes to
T778 249-253 VB denotes have
T779 254-261 VBN denotes reduced
T781 262-271 JJ denotes oxidative
T780 272-280 NN denotes capacity
T782 280-282 , denotes ,
T783 282-291 VBN denotes increased
T785 292-302 JJ denotes glycolytic
T784 303-311 NN denotes capacity
T786 311-313 , denotes ,
T787 313-316 CC denotes and
T788 317-318 DT denotes a
T790 319-328 VBN denotes decreased
T789 329-339 NN denotes percentage
T791 340-342 IN denotes of
T792 343-347 NN denotes type
T794 348-349 CD denotes I
T793 350-356 NNS denotes fibers
T795 357-358 -LRB- denotes (
T796 358-364 NNP denotes Hickey
T797 365-367 FW denotes et
T798 368-371 FW denotes al.
T799 372-376 CD denotes 1995
T800 376-377 : denotes ;
T801 378-384 NNP denotes Tanner
T802 385-387 FW denotes et
T803 388-391 FW denotes al.
T804 392-396 CD denotes 2002
T805 396-397 -RRB- denotes )
T806 397-398 . denotes .
T807 398-506 sentence denotes Similar observations have been made in type 2 diabetic patients (Lillioja et al. 1987; Hickey et al. 1995).
T808 399-406 JJ denotes Similar
T809 407-419 NNS denotes observations
T811 420-424 VBP denotes have
T812 425-429 VBN denotes been
T810 430-434 VBN denotes made
T813 435-437 IN denotes in
T814 438-442 NN denotes type
T816 443-444 CD denotes 2
T815 445-453 JJ denotes diabetic
T817 454-462 NNS denotes patients
T818 463-464 -LRB- denotes (
T819 464-472 NNP denotes Lillioja
T820 473-475 FW denotes et
T821 476-479 FW denotes al.
T822 480-484 CD denotes 1987
T823 484-485 : denotes ;
T824 486-492 NNP denotes Hickey
T825 493-495 FW denotes et
T826 496-499 FW denotes al.
T827 500-504 CD denotes 1995
T828 504-505 -RRB- denotes )
T829 505-506 . denotes .
T830 506-671 sentence denotes Recently, it has been shown that increasing oxidative fibers can lead to improved insulin action and reduced adipocyte size (Luquet et al. 2003; Ryder et al. 2003).
T831 507-515 RB denotes Recently
T833 515-517 , denotes ,
T834 517-519 PRP denotes it
T835 520-523 VBZ denotes has
T836 524-528 VBN denotes been
T832 529-534 VBN denotes shown
T837 535-539 IN denotes that
T839 540-550 VBG denotes increasing
T841 551-560 JJ denotes oxidative
T840 561-567 NNS denotes fibers
T842 568-571 MD denotes can
T838 572-576 VB denotes lead
T843 577-579 IN denotes to
T844 580-588 VBN denotes improved
T846 589-596 NN denotes insulin
T845 597-603 NN denotes action
T847 604-607 CC denotes and
T848 608-615 VBN denotes reduced
T850 616-625 NN denotes adipocyte
T849 626-630 NN denotes size
T851 631-632 -LRB- denotes (
T852 632-638 NNP denotes Luquet
T853 639-641 FW denotes et
T854 642-645 FW denotes al.
T855 646-650 CD denotes 2003
T856 650-651 : denotes ;
T857 652-657 NNP denotes Ryder
T858 658-660 FW denotes et
T859 661-664 FW denotes al.
T860 665-669 CD denotes 2003
T861 669-670 -RRB- denotes )
T862 670-671 . denotes .
R477 T728 T729 compound Muscle,specification
R478 T729 T731 nsubj specification,appears
R479 T730 T729 compound fiber,specification
R480 T732 T733 aux to,associated
R481 T733 T731 xcomp associated,appears
R482 T734 T733 auxpass be,associated
R483 T735 T733 prep with,associated
R484 T736 T735 pobj obesity,with
R485 T737 T736 cc and,obesity
R486 T738 T736 conj diabetes,obesity
R487 T739 T731 punct .,appears
R488 T741 T742 prep For,possess
R489 T743 T741 pobj instance,For
R490 T744 T742 punct ", ",possess
R491 T745 T742 nsubj rodents,possess
R492 T746 T747 dep that,gain
R493 T747 T745 relcl gain,rodents
R494 T748 T749 det the,weight
R495 T749 T747 dobj weight,gain
R496 T750 T749 amod most,weight
R497 T751 T747 prep on,gain
R498 T752 T753 amod high,fat
R499 T753 T755 compound fat,diets
R500 T754 T753 punct -,fat
R501 T755 T751 pobj diets,on
R502 T756 T757 amod fewer,fibers
R503 T757 T742 dobj fibers,possess
R504 T758 T757 nmod type,fibers
R505 T759 T758 nummod I,type
R506 T760 T761 punct (,Abou
R507 T761 T742 meta Abou,possess
R508 T762 T761 nmod et,Abou
R509 T763 T761 nmod al.,Abou
R510 T764 T761 nummod 1992,Abou
R511 T765 T761 punct ),Abou
R512 T766 T742 punct .,possess
R513 T768 T769 prep In,observed
R514 T770 T771 amod obese,patients
R515 T771 T768 pobj patients,In
R516 T772 T769 punct ", ",observed
R517 T773 T774 amod skeletal,muscle
R518 T774 T769 nsubjpass muscle,observed
R519 T775 T769 aux has,observed
R520 T776 T769 auxpass been,observed
R521 T777 T778 aux to,have
R522 T778 T769 xcomp have,observed
R523 T779 T780 amod reduced,capacity
R524 T780 T778 dobj capacity,have
R525 T781 T780 amod oxidative,capacity
R526 T782 T780 punct ", ",capacity
R527 T783 T784 amod increased,capacity
R528 T784 T780 conj capacity,capacity
R529 T785 T784 amod glycolytic,capacity
R530 T786 T784 punct ", ",capacity
R531 T787 T784 cc and,capacity
R532 T788 T789 det a,percentage
R533 T789 T784 conj percentage,capacity
R534 T790 T789 amod decreased,percentage
R535 T791 T789 prep of,percentage
R536 T792 T793 nmod type,fibers
R537 T793 T791 pobj fibers,of
R538 T794 T792 nummod I,type
R539 T795 T796 punct (,Hickey
R540 T796 T769 meta Hickey,observed
R541 T797 T796 nmod et,Hickey
R542 T798 T796 nmod al.,Hickey
R543 T799 T796 nummod 1995,Hickey
R544 T800 T796 punct ;,Hickey
R545 T801 T796 nmod Tanner,Hickey
R546 T802 T796 nmod et,Hickey
R547 T803 T796 nmod al.,Hickey
R548 T804 T796 nummod 2002,Hickey
R549 T805 T796 punct ),Hickey
R550 T806 T769 punct .,observed
R551 T808 T809 amod Similar,observations
R552 T809 T810 nsubjpass observations,made
R553 T811 T810 aux have,made
R554 T812 T810 auxpass been,made
R555 T813 T810 prep in,made
R556 T814 T815 npadvmod type,diabetic
R557 T815 T817 amod diabetic,patients
R558 T816 T814 nummod 2,type
R559 T817 T813 pobj patients,in
R560 T818 T819 punct (,Lillioja
R561 T819 T810 meta Lillioja,made
R562 T820 T819 nmod et,Lillioja
R563 T821 T819 nmod al.,Lillioja
R564 T822 T819 nummod 1987,Lillioja
R565 T823 T819 punct ;,Lillioja
R566 T824 T819 nmod Hickey,Lillioja
R567 T825 T819 nmod et,Lillioja
R568 T826 T819 nmod al.,Lillioja
R569 T827 T819 nummod 1995,Lillioja
R570 T828 T819 punct ),Lillioja
R571 T829 T810 punct .,made
R572 T831 T832 advmod Recently,shown
R573 T833 T832 punct ", ",shown
R574 T834 T832 nsubjpass it,shown
R575 T835 T832 aux has,shown
R576 T836 T832 auxpass been,shown
R577 T837 T838 mark that,lead
R578 T838 T832 ccomp lead,shown
R579 T839 T840 amod increasing,fibers
R580 T840 T838 nsubj fibers,lead
R581 T841 T840 amod oxidative,fibers
R582 T842 T838 aux can,lead
R583 T843 T838 prep to,lead
R584 T844 T845 amod improved,action
R585 T845 T843 pobj action,to
R586 T846 T845 compound insulin,action
R587 T847 T845 cc and,action
R588 T848 T849 amod reduced,size
R589 T849 T845 conj size,action
R590 T850 T849 compound adipocyte,size
R591 T851 T852 punct (,Luquet
R592 T852 T832 meta Luquet,shown
R593 T853 T852 nmod et,Luquet
R594 T854 T852 nmod al.,Luquet
R595 T855 T852 nummod 2003,Luquet
R596 T856 T852 punct ;,Luquet
R597 T857 T852 nmod Ryder,Luquet
R598 T858 T852 nmod et,Luquet
R599 T859 T852 nmod al.,Luquet
R600 T860 T852 nummod 2003,Luquet
R601 T861 T852 punct ),Luquet
R602 T862 T832 punct .,shown